Department of Health and Human Services. Photo: Alex Wong/Getty Images

The Department of Health and Human Services said Monday it cancelled a contract between Advanced Bioscience Resources and the Food and Drug Administration that supplied fetal tissue for research, due to uncertainty that the contract used appropriate protections and followed procurement policy.

The big picture: HHS also says that it’s reviewing "all research involving fetal tissue" and vowed to consider "the serious regulatory, moral, and ethical considerations involved."

Background: Fetal tissue is mostly collected from elective abortions and can be used for research into vaccines, Zika, and genetic diseases. 

Why now? CNN reports that the FDA said in June it plans to purchase about $16,000 of "human fetal tissue" for tests to understand how humans may respond to medications.

  • This prompted backlash from Republicans, who urged the FDA earlier this month in a letter to cancel the contract.

Meanwhile, some scientists have expressed concern over interrupted research. Per STAT, Alta Charo, a University of Wisconsin bioethics professor who has testified before Congress on this topic before, says:

“The use of fetal tissue is important or even necessary for some kinds of work.”

Go deeper

Fauci clashes with Rand Paul at COVID hearing: "You're not listening"

Top health expert Anthony Fauci rebuked Sen. Rand Paul (R-Ky.) at a hearing on Wednesday over his suggestion that New York's COVID-19 infection rate is low because the population there has reached herd immunity.

The big picture: Paul, a libertarian who has criticized government lockdown measures as "authoritarian," has clashed with Fauci in previous hearings. Paul accused Fauci of being a "big fan" of New York Gov. Andrew Cuomo and his lockdown restrictions, while Fauci said the Kentucky senator has repeatedly "misconstrued" his comments.

FDA chief vows agency will not accept political pressure on coronavirus vaccine

Food and Drug Administration Commissioner Stephen Hahn promised that "science will guide our decision" for a coronavirus vaccine at a Senate hearing on Wednesday.

Why it matters: More Americans are expressing doubt about a first-generation vaccine, despite President Trump's efforts to push an unrealistic timeline that conflicts with medical experts in his administration.

CEO confidence rises for the first time in over 2 years

Data: Business Roundtable; Chart: Naema Ahmed/Axios

A closely-watched CEO economic confidence index rose for the first time after declining for nine straight quarters, according to a survey of 150 chief executives of the biggest U.S. companies by trade group Business Roundtable.

Why it matters: The index, which still remains at a decade low, reflects corporate America's expectations for sales, hiring and spending — which plummeted amid uncertainty when the pandemic hit.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!